Strong Alliances, Jointly Initiating a New Chapter in Precision Anesthesia

— Amestar has entered into a strategic cooperation with Medtronic, a global medical technology giant, to jointly promote the 'Combined Visual Double-Lumen Endobronchial Tube'.

At the National Anesthesia Academic Conference held in Xiamen on September 19, 2025, Amestar—a rising force in China’s anesthesia and respiratory field—and Medtronic, a globally leading medical technology company, jointly announced the official launch of their strategic cooperation. The collaboration will focus on Amestar’s innovative product, the 'Combined Visual Double-Lumen Endobronchial Tube,' and conduct in-depth cooperation in areas including academic promotion, clinical application, and market expansion. The signing ceremony was held in a lively atmosphere, attracting the attention of many participating experts and industry peers, and marking a solid step forward for China in the field of high-end airway management devices.

Focus on Clinical Pain Points, Lead Innovations in One-Lung Ventilation Technology

With the rapid development of thoracic surgery, minimally invasive cardiac surgery, robotic surgery, and severe trauma treatment technologies, one-lung ventilation technology has become a core component of modern anesthesia management. Facing new challenges such as the increasingly complex underlying diseases of patients and the prolonged duration of surgeries, clinical practice has put forward unprecedentedly high requirements for the accuracy of airway management, the reliability of lung isolation, and patient safety.

Amestar’s independently developed Combined Visual Double-Lumen Endobronchial Tube is an innovative solution tailored to this urgent clinical need. This product breaks through traditional technical barriers and innovatively combines visualization technology with the design of internal and external double-lumen tubes, achieving core advantages including precise positioning, easy operation, reduced trauma, and the ability to perform both occlusion and ventilation. It not only significantly reduces the workload of medical staff and improves operating room turnover efficiency but also effectively lowers the risk of airway-related complications in patients after surgery, providing strong technical support for enhancing the overall treatment quality of patients undergoing thoracic and severe surgery.

A Powerful Alliance to Empower Precision Medicine

As a leading publicly listed enterprise in the global medical device industry, Medtronic boasts outstanding brand influence, a mature academic promotion system, and a global market network. The achievement of this strategic cooperation represents high recognition from an international giant for the innovation capabilities and product competitiveness of Chinese local enterprises. Medtronic’s strong academic promotion capabilities will provide a broader platform for the clinical application of the 'Combined Visual Double-Lumen Endobronchial Tube,' accelerating the process of making this advanced technology benefit more medical institutions and patients.

For Amestar, this cooperation marks a significant milestone in its development journey. Amestar has always been committed to creating high-quality anesthesia and respiratory medical devices through continuous innovation. The collaboration with Medtronic will greatly help Amestar enhance its brand influence, expand its market channels, and accelerate its strategic goal of becoming a leading enterprise in China’s anesthesia and respiratory medical device industry.

Set Sail Together for a Shared Future

This strategic collaboration between Amestar and Medtronic is not only a business partnership between the two enterprises, but also a key initiative to advance the precision and intelligent development of perioperative medicine in China. Both parties stated that they will take this cooperation as a starting point, give full play to their respective advantages, and work together to bring safer, more efficient, and more precise medical solutions to the market. This joint effort aims to create greater value for clinicians and patients in China and around the world, and to build a new future of precision anesthesia hand in hand.